missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

Applied Biosystems™ TaqPath™ COVID-19 Combo Kit DFS Item

The Applied Biosystems TaqPath COVID-19 Combo Kit is a fast, highly sensitive multiplex diagnostic solution that contains the assays and controls needed for the real-time PCR detection of RNA from the SARS-CoV-2 virus.

Manufacturer:  Applied Biosystems™ A47814

Catalog No. A47814

Please call Customer Service at 1-800-234-7437 or send an email to help@thermofisher.com for assistance.


Description

Description

  • A complete workflow from viral RNA extraction from up to 94 specimens and genetic analysis using real-time PCR to diagnostic report generation in under 4 hours
  • Targeted specificity to 100% of currently available complete genomes for SARS-CoV-2
  • Assay targets spike (S), nucleocapsid (N), and Orf1ab (ORF1ab) protein regions having higher specificity and exhibiting lower risk for mutation
  • COVID-19 Interpretive Software, which automatically converts genetic analysis data into diagnosis, helping reduce risk of user interpretation error
  • The TaqPath COVID-19 Combo Kit consists of both the TaqPath RT-PCR COVID-19 Kit and the TaqPath COVID-19 Control Kit for simplified ordering
  • Kit is approved for use with RNA extracted from nasopharyngeal swabs, nasopharyngeal aspirate (nasal aspirate), and bronchoalveolar lavage (BAL) from patients at risk of exposure to the SARS-CoV-2 virus or with signs and symptoms of COVID-19
  • Recommended for use with either the Applied Biosystems 7500 Fast Dx Real-Time PCR System or the 7500 Fast Real-Time PCR System (RUO version) and the associated Applied Biosystems COVID-19 Interpretive Software

The TaqPath COVID-19 Combo Kit includes the following components:

  • TaqPath RT-PCR COVID-19 Kit
    • COVID-19 real-time PCR assay multiplex – multiplexed assays that contain three primer/probe sets specific to different SARS-CoV-2 genomic regions and primers/probes for bacteriophage MS2
    • MS2 phage control – internal process control for nucleic acid extraction
  • TaqPath COVID-19 Control – RNA control that contains targets specific to the SARS-CoV-2 genomic regions targeted by the assays
  • TaqPath COVID-19 Control Dilution Buffer – dilution buffer for the IVT RNA control as defined in the IFU (information for use)

Testing with the TaqPath COVID-19 Combo Kit is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures. The TaqPath COVID-19 Combo Kit is only for use under the Food and Drug Administration’s Emergency Use Authorization.

Specifications

Specifications

  • COVID-19 real-time PCR assay multiplex, 1500 µL, store at –10 to –30°C
  • MS2 phage control, 10 × 1,000 µL, store at –10 to –30°C
  • TaqPath COVID-19 control dilution buffer, 2 × 250 µL per kit, 5 kits included, store at –10 to –30°C
  • TaqPath COVID-19 control (1 x 104 copies/µL), 2 × 10 µL per kit, 5 kits included, store at ≤ –70°C

    Ships under dry ice

COVID-19 diagnostic testing
Dry Ice
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Primer-Probe Detection
TaqPath™
Human
SDS
Documents
Product Certifications
Promotions

Promotions

For Emergency Use Authorization (EUA) only. For prescription use only. For in vitro diagnostic use.